Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1146912

registered interest
date	30/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assurance, if any, they have received that medication brought from new sources other than the EU will meet the same standards as present.
tabling member printed	Baroness Afshar
uin	HL17886
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>All human medicines marketed in the United Kingdom must meet stringent requirements for quality, safety and efficacy set out in UK medicines legislation and supporting guidelines. These apply regardless of the source of the medicine.</p><p>The Medicines and Healthcare products Regulatory Agency (MHRA), the Government body responsible for the safety and licensing of medicines in the UK, regularly inspect pharmaceutical manufacturing plants in the UK and in third countries.</p><p>Regardless of the location of the site of manufacture, the manufacturer must demonstrate to the MHRA that the product is manufactured according to the registered UK licence (marketing authorisation) and to at least the minimum standard detailed in the European Union Guide to Good Manufacturing Practice.</p><p>In addition, each batch of medicine manufactured in a third country is tested within the UK on import and the manufacturing document reviewed by the license holders Qualified Person before being certified for release to the market.</p><p>All these measures will remain in place if the UK leaves the EU.</p> answering member printed Baroness Blackwood of North Oxford question first answered 08/10/2019 14:37:53 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3847 label Biography information for Baroness Afshar

1146921

registered interest
date	30/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	HIV Infection: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what discussions they have had, and intend to have, with local authorities about ensuring PrEP is routinely commissioned as part of HIV prevention services.
tabling member printed	Lord Black of Brentwood
uin	HL17895
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>It has not proved possible to respond to this question in the time available before Prorogation. Ministers will correspond directly with the Member.</p> answering member printed Baroness Blackwood of North Oxford question first answered 08/10/2019 16:24:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4171 label Biography information for Lord Black of Brentwood

1146783

registered interest
date	27/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Hospitals: Admissions
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the most common cause of unplanned admissions to hospitals in England is; and what steps he is taking to reduce the need for those admissions.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	291564
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The most common cause of unplanned admissions from the most recent data available (2018/19) was for those with primary diagnosis of diseases of the digestive system.</p><p>As part of the NHS Long Term Plan there are five workstreams that underpin the Urgent and Emergency Care reform programme. As part of this programme steps taken to reduce the need for admissions have included Same Day Emergency Care which has increased the proportion of people who are not admitted overnight in an emergency. In addition NHS 111 has been enhanced, so that over 50% of people calling the service receive a clinical assessment over the phone and can be offered immediate clinical advice or be referred to the right clinician for a face to face consultation, thereby reducing the need for hospital admissions.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 08/10/2019 13:12:12 answering member 4362 label Biography information for Edward Argar
tabling member	1538 label Biography information for Rosie Cooper

1146145

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Per Capita Costs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what allocation per capita was made by his Department in respect of clinical commissioning group (CCG) services in (a) each CCG in York and North Yorkshire, (b) each region of England and (c) England in each year since 2015 (i) in cash terms and (ii) at constant prices.
tabling member constituency	York Central
tabling member printed	Rachael Maskell
uin	290952
answer	answer is ministerial correction date of answer 04/10/2019 answer text <p>In respect of clinical commissioning group (CCG) services, per capita Yorkshire and the Humber CCGs’ allocations for 2015/16 onwards are shown in the attached table. CCG allocation announcements for 2015 onwards, including the breakdown by region of England and total for England in real terms can be found at the following link:</p><p><a href="https://www.england.nhs.uk/allocations/" target="_blank">https://www.england.nhs.uk/allocations/</a></p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 04/10/2019 12:41:19 question first ministerially corrected 07/10/2019 20:32:20 answering member 4362 label Biography information for Edward Argar attachment 1 file name 20190930 PQ290952 - Yorkshire and the Humber per Capita Allocations Table - V2.xlsx title PQ290952 table previous answer version 137321 answering member constituency Charnwood answering member printed Edward Argar answering member 4362 label Biography information for Edward Argar
tabling member	4471 label Biography information for Rachael Maskell

1146292

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Surgery
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many heart operations they estimate will be cancelled by the NHS in the event of a no-deal Brexit due to a lack of availability of bio-aortic root replacement imports from Italy.
tabling member printed	Lord Bassam of Brighton
uin	HL17787
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU. This includes the supply of bio-aortic root replacement devices.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17788 question first answered 08/10/2019 15:43:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3504 label Biography information for Lord Bassam of Brighton

1146293

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Surgery
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what alternative bio-aortic root replacement supply lines have been developed in the event of a no-deal Brexit interrupting imports from Italy.
tabling member printed	Lord Bassam of Brighton
uin	HL17788
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU. This includes the supply of bio-aortic root replacement devices.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL17787 question first answered 08/10/2019 15:43:55 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3504 label Biography information for Lord Bassam of Brighton

1146294

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diabetes
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to guarantee a continuous supply of insulin for those with type 1 diabetes in the event of a no-deal Brexit.
tabling member printed	Lord Bassam of Brighton
uin	HL17789
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including insulin, once we have left the EU.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages.</p><p>As an example of the preparations being taken by industry to prepare for EU exit, all three suppliers of insulin have publicly stated that they have significantly increased their United Kingdom stockpiles, and have met the Government’s request that they hold at least six weeks’ worth of extra stock in addition to their usual operational stocks.</p> answering member printed Baroness Blackwood of North Oxford question first answered 08/10/2019 15:45:14 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	3504 label Biography information for Lord Bassam of Brighton

1146310

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Nurses: Training
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they will publish figures for student nurse intakes in Northamptonshire for every year since 2010.
tabling member printed	Lord Hunt of Kings Heath
uin	HL17805
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department does not hold this data.</p> answering member printed Baroness Blackwood of North Oxford question first answered 08/10/2019 14:38:47 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1146341

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Flour: Folic Acid
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many submissions were received to the Proposal to add folic acid to flour consultation document by the closing date; and when they expect to publish a response.
tabling member printed	Lord Rooker
uin	HL17836
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The folic acid fortification consultation closed on 9 September 2019 and we received 1,442 responses. A post-consultation update is also available on the consultation webpage online only.</p><p>We are currently in the process of analysing the consultation responses and will respond in due course.</p> answering member printed Baroness Blackwood of North Oxford question first answered 08/10/2019 16:40:58 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	302 label Biography information for Lord Rooker

1146347

registered interest
date	25/09/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Private Sector
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans, if any, they have to conduct an inquiry into standards of care in private mental health units.
tabling member printed	Lord Taylor of Warwick
uin	HL17842
answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>We have no such plans at present. Everybody has the right to receive safe, high-quality care. If care has fallen short of this, the Care Quality Commission (CQC) can use its powers to take action against those responsible.</p><p>The CQC has a key responsibility in the overall assurance of safety and quality of health and adult social care services in England and has commissioned two independent reviews to look at what it could have done differently or better in terms of its regulation and inspection of Whorlton Hall and other services of this kind.</p><p>We are working with the CQC to look at ways in which we can improve the way we hold large independent sector mental health providers with complex structures to account for quality and safety.</p> answering member printed Baroness Blackwood of North Oxford question first answered 08/10/2019 14:34:24 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	1796 label Biography information for Lord Taylor of Warwick